Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
THM
3726
International Tower Hill Mines
THM
$733M
| $69K | ﹤0.01% |
161,859
+32,559
| +25% | +$14.9K |
|
3727
American Coastal Insurance
ACIC
$465M
| $68K | ﹤0.01% |
64,126
-1,000
| -2% | -$478 |
|
3728
Eledon Pharmaceuticals
ELDN
$291M
| $68K | ﹤0.01% |
29,673
-2,200
| -7% | -$5.44K |
|
3729
Spyre Therapeutics
SYRE
$8.98B
| $68K | ﹤0.01% |
6,044
-3,948
| -40% | -$71K |
|
|
EMBK
3730
DELISTED
Embark Technology, Inc. Common Stock
EMBK
| $68K | ﹤0.01% |
20,565
+380
| +2% | +$1.86K |
|
3731
Torrid Holdings
CURV
$228M
| $67K | ﹤0.01% |
22,600
+6,700
| +42% | +$27.3K |
|
3732
Dave Inc
DAVE
$4.03B
| $67K | ﹤0.01% |
+7,263
| New | +$77.6K |
|
3733
Geospace Technologies
GEOS
$67.9M
| $67K | ﹤0.01% |
+15,800
| New | +$68.5K |
|
3734
IZEA Worldwide
IZEA
$53.8M
| $67K | ﹤0.01% |
30,800
+3,775
| +14% | +$9.91K |
|
|
KRKR
3735
36Kr Holdings
KRKR
$6.07M
| $67K | ﹤0.01% |
3,250
+1,420
| +78% | +$29.6K |
|
3736
Laird Superfood
LSF
$46.8M
| $67K | ﹤0.01% |
79,700
-2,100
| -3% | -$3.03K |
|
|
LVTX
3737
DELISTED
LAVA Therapeutics
LVTX
| $66K | ﹤0.01% |
+18,800
| New | +$86.3K |
|
|
TTSH
3738
DELISTED
Tile Shop Holdings
TTSH
| $66K | ﹤0.01% |
15,100
-54,600
| -78% | -$224K |
|
|
TRVN
3739
DELISTED
Trevena, Inc.
TRVN
| $66K | ﹤0.01% |
1,858
+104
| +6% | +$8.64K |
|
|
HZN
3740
DELISTED
Horizon Global Corporation
HZN
| $66K | ﹤0.01% |
168,902
-30,299
| -15% | -$20.7K |
|
3741
Boxlight
BOXL
$4.54M
| $65K | ﹤0.01% |
146
+18
| +14% | +$11.4K |
|
|
SGTX
3742
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $65K | ﹤0.01% |
14,239
+2,215
| +18% | +$12.6K |
|
|
BOXD
3743
DELISTED
Boxed, Inc.
BOXD
| $65K | ﹤0.01% |
+335,137
| New | +$171K |
|
3744
Benitec Biopharma
BNTC
$424M
| $64K | ﹤0.01% |
22,090
+15,006
| +212% | +$50.8K |
|
|
CMCM
3745
Cheetah Mobile
CMCM
$93.7M
| $64K | ﹤0.01% |
34,745
-500
| -1% | -$959 |
|
3746
Aurora
AUR
$13.4B
| $63K | ﹤0.01% |
+52,400
| New | +$89.4K |
|
3747
Evogene
EVGN
$9.67M
| $63K | ﹤0.01% |
8,970
-422
| -4% | -$2.98K |
|
3748
Magic Empire Global Ltd
MEGL
$6.13M
| $63K | ﹤0.01% |
+12,261
| New | +$116K |
|
3749
Upexi
UPXI
$60.5M
| $63K | ﹤0.01% |
1,045
+90
| +9% | +$7.64K |
|
|
GRTX
3750
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $63K | ﹤0.01% |
42,500
-115,268
| -73% | -$187K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.